GenomOncology
PrivateLast Round
Debt
Feb 12, 2021
Total Funding Raised
$2.74M
Company Overview
GenomOncology is a healthtech company that provides a software platform to transform complex clinical and molecular genomic data into actionable intelligence for personalized patient care.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Healthcare Analytics, Clinical Trials, Medical AI, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenomOncology Comparables
Compare GenomOncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomate Health | 82% | |
| CureMatch | 81% | |
| VieCure | 81% | |
GenomOncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 12, 2021 | ||||
| Debt | Apr 27, 2020 | ||||
| Series A | Sep 7, 2016 | ||||
| VC Round | Feb 5, 2014 | ||||
| Seed | Jun 5, 2012 |
Key People
Founding team and executive leadership
GenomOncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KeyBank | Debt |
| JumpStart Ventures | Seed, Series A |
| Zapis Capital Group | Seed |
| TriStar Health Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2021
$637K debt round completed.
- Apr 27, 2020
$604K round led by KeyBank.
GenomOncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GenomOncology's valuation, stock price, and market status.